- Nestle is targeting the boom in GLP-1 weight‑loss drugs (about 16 million U.S. users now) by using AI and nutritional science to develop products tailored to people taking Ozempic/Wegovy.
- The company is designing items to tackle rapid‑weight‑loss issues—muscle loss and “Ozempic face”—adding collagen and high‑protein formulas (e.g., Boost Advanced, Milo PRO) and patenting nutrient blends to support muscle and curb appetite.
- Nutrition experts note whole foods can provide the same benefits and warn of marketing-driven demand, but Nestle says there's a clear market for specialized products.
The news, distilled into what matters.
Get the full experience in the app — topics, comments, and audio summaries.